1. Song YJ, Kim JY, Lee SK, et al. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer. Int J Cancer, 2011, 129(4): 896-902. doi:10.1002/ijc.25741.
2. Kirkegård J, Farkas DK, Søgaard M, et al. Conization as a marker of persistent cervical human papillomavirus (HPV) infection and risk of gastrointestinalcancer: a Danish 34-year nationwide cohort study. Cancer Causes Control, 2014, 25(12): 1677-1682. doi: 10.1007/s10552-014-0473-4.
3. Katki HA, Cheung LC, Fetterman B, et al. A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening. J R Stat Soc Ser A Stat Soc, 2015, 178(4): 903-923. doi: 10.1111/rssa.12101.
4. Zhou C, Steplowski TA, Dickens HK, et al. Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells. PLoS One, 2013, 8(2): e55730. doi: 10.1371/journal.pone.0055730.
5. Miller J, Dakic A, Chen R, et al. HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes. PLoS Pathog, 2013, 9(4): e1003284. doi: 10.1371/journal.ppat.1003284.
6. Peralta-Zaragoza O, De-la-O-Gómez F, Deas J, et al. Selective silencing of gene target expression by siRNA expression plasmids in human cervical cancer cells. Methods Mol Biol, 2015, 1249: 153-171. doi: 10.1007/978-1-4939-2013-6_11.
7. Díaz-González Sdel M, Deas J, Benítez-Boijseauneau O, et al. Utility of microRNAs and siRNAs in cervical carcinogenesis. Biomed Res Int, 2015, 2015: 374924. doi: 10.1155/2015/374924.
8. Shi YA, Zhao Q, Zhang LH, et al. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo. Int J Oncol, 2014, 45(3): 1216-1224. doi: 10.3892/ijo.2014.2493.
9. Nachajova M, Brany D, Dvorska D. Telomerase and the process of cervical carcinogenesis. Tumour Biol, 2015, 36(10): 7335-7338. doi: 10.1007/s13277-015-3976-z.
10. Sui X, Kong N, Wang Z, et al. Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia. Oncol Lett, 2013, 6(2): 317-322. doi: 10.3892/ol.2013.1367.
11. Merghoub N, El Btaouri H, Benbacer L, et al. Inula viscosa extracts induces telomere shortening and apoptosis in cancer cells and overcome drug resistance. Nutr Cancer, 2016, 68(1): 131-143. doi: 10.1080/01635581.2016.1115105.
12. Iarriccio L, Manguán-García C, Pintado-Berninches L, et al. GSE4, a small dyskerin- and GSE24.2-related peptide, induces telomerase activity, cell proliferation and reduces DNA damage, oxidative stress and cell senescence in dyskerin mutant cells. PLoS One, 2015, 10(11): e0142980. doi: 10.1371/journal.pone.0142980.
13. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med, 1999, 5(10): 1164-1170. doi: 10.1038/13495.
14. Panneer Selvam S, De Palma RM, Oaks JJ, et al. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. Sci Signal, 2015, 8(381): ra58. doi: 10.1126/scisignal.aaa4998.
15. Gottumukkala SN, Dwarakanath CD, Sudarsan S.Ribonucleic acid interference induced gene knockdown. J Indian Soc Periodontol, 2013, 17(4): 417-422. doi: 10.4103/0972-124X.118309.
16. Ranjbar B, Krogh LB, Laursen MB, et al. Anti-apoptotic effects of lentiviral vector transduction promote increased rituximab tolerance in cancerous B-cells. PLoS One, 2016, 11(4): e0153069. doi: 10.1371/journal.pone.0153069.
17. Dreyer JL. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions. Mol Biotechnol, 2011, 47(2): 169-187. doi: 10.1007/s12033-010-9334-x.
18. Zhao HK, Mo LZ. Construction of the lentiviral expression vector of human telomerase reverse transcriptase gene small interfering RNA fragments and its expression in cervical cancer caski cells. Chinese J Cancer Prev Contr, 2014, 6(4): 342-347. |